Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12 (Published 2018 Feb 26).
Article PubMed PubMed Central Google Scholar
Altabas V. Drug treatment of metabolic syndrome. Curr Clin Pharmacol. 2013;8(3):224–31. https://doi.org/10.2174/1574884711308030009.
Article CAS PubMed Google Scholar
Villalva CM, Alvarez-Muiño XLL, Mondelo TG, Fachado AA, Fernández JC. Adherence to treatment in hypertension. Adv Exp Med Biol. 2017;956:129–47. https://doi.org/10.1007/5584_2016_77.
Peacock E, Krousel-Wood M. Adherence to antihypertensive therapy. Med Clin North Am. 2017;101(1):229–45. https://doi.org/10.1016/j.mcna.2016.08.005.
Article PubMed PubMed Central Google Scholar
Siraj J, Abateka T, Kebede O. Patients’ adherence to anti-diabetic medications and associated factors in Mizan-Tepi University Teaching Hospital: a cross-sectional study. Inquiry. 2021;58:469580211067477. https://doi.org/10.1177/00469580211067477.
Umeda T, Hayashi A, Fujimoto G, Piao Y, Matsui N, Tokita S. Medication adherence/persistence and demographics of Japanese dyslipidemia patients on statin-ezetimibe as a separate pill combination lipid-lowering therapy- an observational pharmacy claims database study. Circ J. 2019;83(8):1689–97. https://doi.org/10.1253/circj.CJ-18-1344.
Chen D, Zhang H, Shao J, et al. Determinants of adherence to diet and exercise behaviours among individuals with metabolic syndrome based on the Capability, Opportunity, Motivation, and Behaviour model: a cross-sectional study. Eur J Cardiovasc Nurs. 2023;22(2):193–200. https://doi.org/10.1093/eurjcn/zvac034.
Alomar AO, Shaheen MF, Almaneea AS, et al. The effect of bariatric surgery on metabolic syndrome: a three-center experience in Saudi Arabia. Obes Surg. 2021;31(8):3630–6. https://doi.org/10.1007/s11695-021-05461-3.
Wan B, Fang N, Guan W, et al. Cost-effectiveness of bariatric surgery versus medication therapy for obese patients with type 2 diabetes in China: a Markov analysis. J Diabetes Res. 2019;2019:1341963. https://doi.org/10.1155/2019/1341963. (Published 2019 Dec 19).
Article PubMed PubMed Central Google Scholar
Iannelli A, Treacy P, Sebastianelli L, Schiavo L, Martini F. Perioperative complications of sleeve gastrectomy: review of the literature. J Minim Access Surg. 2019;15(1):1–7. https://doi.org/10.4103/jmas.JMAS_271_17.
Article PubMed PubMed Central Google Scholar
Garcia FK, Mulder BC, Hazebroek EJ, Koelen MA, Veen EJ, Verkooijen KT. Bariatric surgery stigma from the perspective of patients: a scoping review. J Adv Nurs. 2024;80(6):2252–72. https://doi.org/10.1111/jan.15994.
Park CH, Nam SJ, Choi HS, et al. Comparative efficacy of bariatric surgery in the treatment of morbid obesity and diabetes mellitus: a systematic review and network meta-analysis. Obes Surg. 2019;29(7):2180–90. https://doi.org/10.1007/s11695-019-03831-6.
Wang L, Lin M, Yu J, et al. The impact of bariatric surgery versus non-surgical treatment on blood pressure: systematic review and meta-analysis. Obes Surg. 2021;31(11):4970–84. https://doi.org/10.1007/s11695-021-05671-9.
Liu DF, Ma ZY, Zhang CS, et al. The effects of bariatric surgery on dyslipidemia and insulin resistance in overweight patients with or without type 2 diabetes: a systematic review and network meta-analysis. Surg Obes Relat Dis. 2021;17(9):1655–72. https://doi.org/10.1016/j.soard.2021.04.005.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71. (Published 2021 Mar 29).
Article PubMed PubMed Central Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. https://doi.org/10.1007/s10654-010-9491-z12.
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. The BMJ. 2019;366. https://doi.org/10.1136/bmj.l4898
Steffen R, Potoczna N, Bieri N, Horber FF. Successful multi-intervention treatment of severe obesity: a 7-year prospective study with 96% follow-up. Obes Surg. 2009;19(1):3–12. https://doi.org/10.1007/s11695-008-9675-8.
Timofte D, Hristov I, Zugun-Eloae F, Ungureanu MC, Galesanu C, Mocanu V. Middle term impact of sleeve gastrectomy on major cardiovascular risk factors in a group of Romanian obese patients. Acta Endocrinol (Buchar). 2017;13(4):454–60. https://doi.org/10.4183/aeb.2017.454.
Article CAS PubMed Google Scholar
Visockiene Z, Brimas G, Abaliksta T, Siauliene L, Liakina V, Strupas K. Metabolic changes one year after laparoscopic adjustable gastric banding operation in morbidly obese subjects. Wideochir Inne Tech Maloinwazyjne. 2013;8(1):13–21. https://doi.org/10.5114/wiitm.2011.30828.
Weiss R, Appelbaum L, Schweiger C, et al. Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diabetes Care. 2009;32(10):1910–5. https://doi.org/10.2337/dc09-0943.
Article PubMed PubMed Central Google Scholar
Yu H, Zhang L, Bao Y, et al. Metabolic syndrome after Roux-en-Y gastric bypass surgery in Chinese obese patients with type 2 diabetes. Obes Surg. 2016;26(9):2190–7. https://doi.org/10.1007/s11695-016-2074-7.
Zetu C, Popa S, Golli AL, Condurache A, Munteanu R. Long-term improvement of dyslipidaemia, hyperuricemia and metabolic syndrome in patients undergoing laparoscopic sleeve gastrectomy. Arch Endocrinol Metab. 2021;64(6):704–9. https://doi.org/10.20945/2359-3997000000273.
Zhang R, Lin B, Parikh M, et al. Lipoprotein insulin resistance score in nondiabetic patients with obesity after bariatric surgery. Surg Obes Relat Dis. 2020;16(10):1554–60. https://doi.org/10.1016/j.soard.2020.05.008.
Article PubMed PubMed Central Google Scholar
Iannelli A, Anty R, Schneck AS, Tran A, Gugenheim J. Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. Surgery. 2011;149(3):364–70. https://doi.org/10.1016/j.surg.2010.08.013.
Iannelli A, Anty R, Schneck AS, Tran A, Hébuterne X, Gugenheim J. Evolution of low-grade systemic inflammation, insulin resistance, anthropometrics, resting energy expenditure and metabolic syndrome after bariatric surgery: a comparative study between gastric bypass and sleeve gastrectomy. J Visc Surg. 2013;150(4):269–75. https://doi.org/10.1016/j.jviscsurg.2013.08.005.
Article CAS PubMed Google Scholar
Lee WJ, Almulaifi AM, Tsou JJ, Ser KH, Lee YC, Chen SC. Duodenal-jejunal bypass with sleeve gastrectomy versus the sleeve gastrectomy procedure alone: the role of duodenal exclusion. Surg Obes Relat Dis. 2015;11(4):765–70. https://doi.org/10.1016/j.soard.2014.12.017.
Martini F, Anty R, Schneck AS, Casanova V, Iannelli A, Gugenheim J. Predictors of metabolic syndrome persistence 1 year after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2015;11(5):1054–60. https://doi.org/10.1016/j.soard.2015.02.019.
Nora M, Guimarães M, Almeida R, et al. Excess body mass index loss predicts metabolic syndrome remission after gastric bypass. Diabetol Metab Syndr. 2014;6(1):1. https://doi.org/10.1186/1758-5996-6-1. (Published 2014 Jan 2).
Article PubMed PubMed Central Google Scholar
Nugent C, Bai C, Elariny H, et al. Metabolic syndrome after laparoscopic bariatric surgery. Obes Surg. 2008;18(10):1278–86. https://doi.org/10.1007/s11695-008-9511-1.
Gazzaruso C, Giordanetti S, La Manna A, et al. Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome. Obes
Comments (0)